Clinical evaluation of a sustained release compared to a standard formulation of tiaprofenic acid (Surgam) in rheumatoid arthritis: a Canadian multicenter study.

@article{Buchanan1991ClinicalEO,
  title={Clinical evaluation of a sustained release compared to a standard formulation of tiaprofenic acid (Surgam) in rheumatoid arthritis: a Canadian multicenter study.},
  author={Walter Buchanan and Walter F. Kean and J St-Jean and E. M. Gerecz-Simon and Robert Elie},
  journal={The Journal of rheumatology},
  year={1991},
  volume={18 7},
  pages={1046-54}
}
A double blind, randomized, parallel group clinical therapeutic trial, comparing a sustained release formulation with a standard preparation of tiaprofenic acid (Surgam), was performed in 119 patients with rheumatoid arthritis. The sustained release preparation was prescribed as two 300 mg capsules taken once a day, and the standard formulation as one tablet of 300 mg taken twice a day. From baseline up to the 3rd and 6th week of treatment, a statistically significant difference (p less than 0… CONTINUE READING

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…